OncLive® On Air

Orlowski on Isa-VRd in Transplant-Ineligible Multiple Myeloma

Season 10, Episode 43, Jul 11, 08:25 PM

Headliner

Embed code See more options

Dr Orlowski discusses key efficacy data from the IMROZ trial of Isa-VRd in newly diagnosed, transplant-ineligible multiple myeloma.

Audioboom uses Javascript

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

Sorry, your browser isn't supported by Audioboom.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.